Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0133260001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Cancelled Pre Market | 02408848 | AGILA JAMP CANADA INC | AJ-CISATRACURIUM | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Cancelled Pre Market | 02408856 | AGILA JAMP CANADA INC | AJ-CISATRACURIUM | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Cancelled Pre Market | 02406519 | MYLAN PHARMACEUTICALS ULC | CISATRACURIUM BESYLATE INJECTION | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Cancelled Post Market | 02425718 | PFIZER CANADA ULC | CISATRACURIUM BESYLATE INJECTION | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Cancelled Pre Market | 02457385 | ACCORD HEALTHCARE INC | CISATRACURIUM BESYLATE INJECTION | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Cancelled Pre Market | 02406527 | MYLAN PHARMACEUTICALS ULC | CISATRACURIUM BESYLATE INJECTION (PRESERVATIVE-FREE) | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Approved | 02423782 | FRESENIUS KABI CANADA LTD | CISATRACURIUM BESYLATE INJECTION MULTI-DOSE | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Approved | 02423774 | FRESENIUS KABI CANADA LTD | CISATRACURIUM BESYLATE INJECTION SINGLE DOSE | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Marketed | 02408813 | OMEGA LABORATORIES LIMITED | CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Dormant | 02408805 | OMEGA LABORATORIES LIMITED | CISATRACURIUM OMEGA SINGLE DOSE | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Cancelled Post Market | 02229422 | ABBVIE CORPORATION | NIMBEX | Human | Yes | Prescription | 1 | CISATRACURIUM (CISATRACURIUM BESYLATE) | 2 MG / ML |
Application information
Related information
Contact us
Version 4.0.3